Hyperion DeFi Inc.: Leading Eye‑Disease Innovation Amid Stock Volatility
Hyperion DeFi Inc. is pioneering eye‑disease treatments—from glaucoma to dry eye—while navigating biotech volatility, aiming to deliver innovative ophthalmology therapies that improve patient outcomes.
3 minutes to read